COVID19 Spahn: „Arzneimittel sind keine Ware wie jede andere – da braucht es klare Regeln bei den Preisen.”am 10. September 2020 um 22:00 2 years ago Continue ReadingPrevious: The 2019 FDA Science Forumam 20. November 2020 um 21:30Next: FDA Approves First Treatment for Hutchinson-Gilford Progeria Syndrome and Some Progeroid Laminopathiesam 20. November 2020 um 22:30 Related Stories Long Covid: Three years and no magic bulleton 26. March 2023 at 2:18 1 min read COVID19 Long Covid: Three years and no magic bulleton 26. March 2023 at 2:18 16 mins ago ‘Live free and die’? The sad state of U.S. life expectancyon 25. March 2023 at 11:01 1 min read COVID19 ‘Live free and die’? The sad state of U.S. life expectancyon 25. March 2023 at 11:01 14 hours ago Situationsbericht vom 24.3.2023on 24. March 2023 at 10:30 1 min read COVID19 Situationsbericht vom 24.3.2023on 24. March 2023 at 10:30 1 day ago Situation report – 24 March 2023on 24. March 2023 at 10:30 1 min read COVID19 Situation report – 24 March 2023on 24. March 2023 at 10:30 1 day ago FDA Roundup: March 24, 2023on 24. March 2023 at 19:22 5 min read COVID19 FDA Roundup: March 24, 2023on 24. March 2023 at 19:22 1 day ago FDA approves first treatment for activated phosphoinositide 3-kinase delta syndromeon 23. March 2023 at 18:39 3 min read COVID19 FDA approves first treatment for activated phosphoinositide 3-kinase delta syndromeon 23. March 2023 at 18:39 1 day ago
